{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:19:42Z","timestamp":1784225982666,"version":"3.55.0"},"reference-count":41,"publisher":"Tech Science Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2024.052133","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T04:47:55Z","timestamp":1721018875000},"page":"687-694","source":"Crossref","is-referenced-by-count":3,"title":["Preventive effects of low-dose radiation and hypofractionated radiation plus anti-programmed cell death protein 1 on lung metastasis in breast cancer"],"prefix":"10.32604","volume":"33","author":[{"given":"SHUANG","family":"CHEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XINGTING","family":"HE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KEWEI","family":"XIANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GUIHONG","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XUEMEI","family":"DENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HONGRU","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s00066-023-02122-5","article-title":"DNA as the main target in radiotherapy-a historical overview from first isolation to anti-tumour immune response","volume":"199","author":"Frey","year":"2023","journal-title":"Strahlenther Onkol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e000537","DOI":"10.1136\/jitc-2020-000537","article-title":"Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma","volume":"8","author":"Barsoumian","year":"2020","journal-title":"J Immunother Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.3390\/ijms22137204","article-title":"The abscopal effect in the era of checkpoint inhibitors","volume":"22","author":"Kodet","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12032-018-1080-0","article-title":"The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma","volume":"35","author":"Uryvaev","year":"2018","journal-title":"Med Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13045-020-00940-z","article-title":"SBRT combined with PD-1\/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges","volume":"13","author":"Chen","year":"2020","journal-title":"J Hematol Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e000289","DOI":"10.1136\/jitc-2019-000289","article-title":"Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity","volume":"8","author":"Chen","year":"2020","journal-title":"J Immunother Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/1078-0432.CCR-20-2293","article-title":"High-dose per fraction radiotherapy induces both antitumor immunity and immunosuppressive responses in prostate tumors","volume":"27","author":"Lin","year":"2021","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","article-title":"Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy","volume":"12","author":"Herrera","year":"2022","journal-title":"Cancer Discov"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.7150\/thno.44871","article-title":"CDK4\/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1158\/1078-0432.CCR-20-4632","article-title":"A randomized trial of combined PD-L1 and CTLA-4 inhibition with targeted low-dose or hypofractionated radiation for patients with metastatic colorectal cancer","volume":"27","author":"Monjazeb","year":"2021","journal-title":"Clin Cancer Res"},{"key":"ref12","first-page":"65","article-title":"Radiotherapy combination opportunities leveraging immunity for the next oncology practice","volume":"67","author":"Herrera","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.currproblcancer.2015.10.003","article-title":"The immune mechanisms of abscopal effect in radiation therapy","volume":"40","author":"Grass","year":"2016","journal-title":"Curr Probl Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/1078-0432.CCR-18-3518","article-title":"Postablation modulation after single high-dose radiation therapy improves tumor control via enhanced immunomodulation","volume":"26","author":"Savage","year":"2020","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1158\/0008-5472.CAN-15-3142","article-title":"Suppression of type I IFN signaling in tumors mediates resistance to anti-PD-1 treatment that can be overcome by radiotherapy","volume":"77","author":"Wang","year":"2017","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijrobp.2020.05.002","article-title":"Effect of low-dose radiation therapy on abscopal responses to hypofractionated radiation therapy and anti-PD1 in mice and patients with non-small cell lung cancer","volume":"108","author":"Yin","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1158\/1078-0432.CCR-19-0795","article-title":"Triple therapy with MerTK and PD1 inhibition plus radiotherapy promotes abscopal antitumor immune responses","volume":"25","author":"Caetano","year":"2019","journal-title":"Clin Cancer Res"},{"key":"ref18","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41416-020-01161-4","article-title":"The lingering mysteries of metastatic recurrence in breast cancer","volume":"124","author":"Riggio","year":"2021","journal-title":"Br J Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","article-title":"Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets","volume":"60","author":"Liang","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-med-042716-103422","article-title":"Novel radiotherapy techniques for breast cancer","volume":"69","author":"Bradley","year":"2018","journal-title":"Annu Rev Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00432-018-2644-2","article-title":"Patterns of breast cancer relapse in accordance to biological subtype","volume":"144","author":"Ignatov","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fimmu.2019.00317","article-title":"Low-dose total body irradiation can enhance systemic immune related response induced by hypo-fractionated radiation","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mrm.29457","article-title":"Time-dependent diffusivity and kurtosis in phantoms and patients with head and neck cancer","volume":"89","author":"Solomon","year":"2023","journal-title":"Magn Reson Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"110026","DOI":"10.1016\/j.intimp.2023.110026","article-title":"Effect of triple therapy with low-dose total body irradiation and hypo-fractionated radiation plus anti-programmed cell death protein 1 blockade on abscopal antitumor immune responses in breast cancer","volume":"117","author":"Liu","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1201500","DOI":"10.3389\/fonc.2023.1201500","article-title":"A review on lymphocyte radiosensitivity and its impact on radiotherapy","volume":"13","author":"Paganetti","year":"2023","journal-title":"Front Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","volume":"24","author":"Klug","year":"2013","journal-title":"Cancer Cell"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"10053","DOI":"10.1007\/s00432-023-04928-3","article-title":"Low-dose total body irradiation enhances systemic anti-tumor immunity induced by local cryotherapy","volume":"149","author":"Liao","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/mc.22879","article-title":"Low dose radiation primed iNOS + M1macrophages modulate angiogenic programming of tumor derived endothelium","volume":"57","author":"Nadella","year":"2018","journal-title":"Mol Carcinog"},{"key":"ref30","first-page":"E7240","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","first-page":"1193","article-title":"Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy","volume":"53","author":"Wang","year":"2018","journal-title":"Int J Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e001001","DOI":"10.1136\/jitc-2020-001001","article-title":"Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I\/II trial","volume":"8","author":"Welsh","year":"2020","journal-title":"J Immunother Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijrobp.2017.06.2452","article-title":"Decreased survival after combining thoracic irradiation and an anti-PD-1 antibody correlated with increased T-cell infiltration into cardiac and lung tissues","volume":"99","author":"Myers","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S2213-2600(20)30391-X","article-title":"Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"9","author":"Theelen","year":"2021","journal-title":"Lancet Respir Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijrobp.2018.01.094","article-title":"Abscopal effects with hypofractionated schedules extending into the effector phase of the tumor-specific T-cell response","volume":"101","author":"Zhang","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1158\/0008-5472.CAN-16-0549","article-title":"Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming","volume":"76","author":"Rodriguez-Ruiz","year":"2016","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/1535-7163.MCT-18-0558","article-title":"TGF\u03b2 blockade enhances radiotherapy abscopal efficacy effects in combination with anti-PD1 and anti-CD137 immunostimulatory monoclonal antibodies","volume":"18","author":"Rodr\u00edguez-Ruiz","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3389\/fimmu.2020.01680","article-title":"The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion","volume":"11","author":"De Cicco","year":"2020","journal-title":"Front Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"585214","DOI":"10.3389\/fimmu.2020.585214","article-title":"Immunotherapy targeting myeloid-derived suppressor cells (MDSCs) in tumor microenvironment","volume":"11","author":"Gao","year":"2021","journal-title":"Front Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3892\/ol.2022.13578","article-title":"Near complete remission of a locally advanced giant melanoma of the vulva following hypo-fractionated radiotherapy and immune checkpoint inhibitors: a case report","volume":"24","author":"Chen","year":"2022","journal-title":"Oncol Lett"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-3\/OncolRes-33-03-52133\/OncolRes-33-52133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T06:22:56Z","timestamp":1763101376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n3\/59638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2024.052133","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}